In real-world conditions, patients achieved a mean weight loss of 7.88 %, with a median weight loss of 5.9 %
See if you may qualify Last updated: June 13, 2026 If youve recently started taking tirzepatide or another GLP-1 medication for weight loss, you might be surprised to experience joint pain alongside your impressive results on the scale
These challenges have led many manufacturers to explore fragment-based synthesis strategies for long peptides
This sample is then analyzed to determine the concentration of Vitamin B12 present
Network meta-analyses suggest that SGLT2is may exert greater effects on reducing alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels
Novo Nordisk, the company that makes these weight-loss drugs, failed to warn about the increased risk of gastroparesis (also known as frozen stomach) for people taking GLP-1 RA treatments